(Q53559624)

English

Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

0 references

author name string

Hideo Tanaka

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Takuo Ito

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Taiichi Kyo

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Akiro Kimura

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

publication date

1 May 2007

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

European Journal of Haematology

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

78

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

389-398

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Chronic myeloid leukemia-still a few questions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Dynamics of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

TRAIL and its receptors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

The neutrophil as a cellular source of chemokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Acceleration of human neutrophil apoptosis by TRAIL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00834.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2007.00834.X

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17432976

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53559624&oldid=942171951"